|
|
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...."
|
1R01CA134458-01A2
|
$315,400
|
$315,400
|
SKORSKI, TOMASZ
|
TEMPLE UNIVERSITY
|
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5K99CA134743-02
|
$140,940
|
$112,752
|
Feng, Hui
|
DANA-FARBER CANCER INSTITUTE
|
|
|
. Methylation and silencing of human p15INK4b in acute myeloid leukemia
|
ZIA BC 011034
|
$293,830
|
$293,830
|
Wolff, Linda
|
CCR (NCI)
|
|
|
8-Chloro-Adenosine for Treatment of CLL (IND 68,229)
|
5R21CA112907-02
|
$305,800
|
$305,800
|
WIERDA, WILLIAM
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$889,165
|
$355,666
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
|
A collaborative case-control study of childhood leukemia and EMF and radon exposu
|
ZIA CP010135 04040
|
$240,374
|
$240,374
|
Linet, Martha
|
DCEG (NCI)
|
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-05
|
$313,901
|
$251,121
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMA
|
ZIA CP010121 10363
|
$44,311
|
$44,311
|
Lan, Qing
|
DCEG (NCI)
|
|
|
A Novel Expansion of Primary Leukemia Stem Cells
|
1R43CA156921-01
|
$304,943
|
$304,943
|
SAKTHIVEL, RAMASAMY
|
ARTERIOCYTE, INC.
|
|
|
A Novel Screen for Compounds that Outflank BCR-ABL Drug-Resistance
|
5R01CA136699-02
|
$315,371
|
$315,371
|
COLICELLI, JOHN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
1K08CA140720-01A1
|
$145,979
|
$145,979
|
Druley, Todd
|
WASHINGTON UNIVERSITY
|
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
5R01CA129974-04
|
$324,900
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Patient-Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
|
1R43CA144362-01A1
|
$154,707
|
$38,677
|
Wiener, Matthew
|
PHARMATECH, INC.
|
|
|
A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients
|
1R21CA153018-01
|
$332,000
|
$332,000
|
Gewirtz, Alan
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$344,821
|
$34,482
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-17
|
$264,061
|
$211,249
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$1,684,362
|
$84,218
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S6
|
$7,064,076
|
$423,845
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S7
|
$100,000
|
$6,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S8
|
$50,000
|
$3,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
$30,445
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$289,223
|
$144,612
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-04
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-02
|
$393,420
|
$393,420
|
Brentjens, Renier
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Adoptive T-Cell Therapy for Acute Leukemia
|
1R21CA132277-01A2
|
$320,588
|
$320,588
|
BALL, EDWARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Adult Leukemia Research Center
|
5P01CA018029-35
|
$4,628,534
|
$4,628,534
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
5R44CA114126-04
|
$419,983
|
$419,983
|
Lim, Mark
|
AMBERGEN, INC
|
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119 10527
|
$143,853
|
$71,926
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
5R01CA139032-02
|
$332,000
|
$332,000
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-05
|
$313,613
|
$313,613
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
|
Analysis of higher order chromatin structures in normal and cancer epigenomes
|
1R01CA140485-01A1
|
$343,413
|
$343,413
|
Kim, Tae Hoon
|
YALE UNIVERSITY
|
|
|
Analysis of the leukemic stem cell niche in chronic myeloid leukemia
|
1K08CA138916-01A1
|
$156,444
|
$156,444
|
Krause, Daniela
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,506,107
|
$75,305
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Animal models to study the role of INK4b loss in human acute myeloid leukemia
|
ZIA BC 011027
|
$391,773
|
$391,773
|
Wolff, Linda
|
CCR (NCI)
|
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
ZIA BC 010647
|
$377,603
|
$188,802
|
Rader, Christoph
|
CCR (NCI)
|
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-23
|
$340,333
|
$340,333
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Antileukemic effort of NK cells in HCT for pediatric AML
|
5R01CA120583-04
|
$362,276
|
$362,276
|
LEUNG, WING
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-24
|
$384,546
|
$153,818
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-05
|
$255,536
|
$255,536
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
|
Application of 454 Sequencing to Cancer Epigenomics
|
5R33CA134304-02
|
$315,300
|
$315,300
|
SHI, HUIDONG
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
|
Aptamer Based Technology for Molecular Analysis of Leukemia
|
5R01CA129311-03
|
$303,988
|
$303,988
|
Li, Ying
|
UNIVERSITY OF FLORIDA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
$2,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
$2,878
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
$2,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
$83,238
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arsenic Trioxide Activaed Pathways in APL
|
5R01CA121192-05
|
$260,253
|
$260,253
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
|
|
Arsenic Trioxide and Acute Myeloid Leukemia
|
5R01CA093533-07
|
$255,098
|
$255,098
|
JING, YONGKUI
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
|
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis
|
5K01CA117914-05
|
$152,703
|
$152,703
|
RIVERA, AMARILIZ
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Assays for Screening Histone Modifications in Cancer
|
2R01CA107106-05A2
|
$233,752
|
$233,752
|
FREITAS, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
$25,614
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Total relevant funding to Leukemia for this search: $239,689,242
|
